Viking Therapeutics
VKTX
#3593
Rank
NZ$4.70 B
Marketcap
$41.88
Share price
-2.61%
Change (1 day)
-61.79%
Change (1 year)

Earnings for Viking Therapeutics (VKTX)

Earnings in 2024 (TTM): -NZ$0.19 Billion

According to Viking Therapeutics 's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -NZ$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viking Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$0.19 Billion28.02%
2023 -NZ$0.15 Billion24.73%
2022 -NZ$0.12 Billion25.24%
2021 -NZ$92.16 Million39.23%
2020 -NZ$66.19 Million53.21%
2019 -NZ$43.21 Million16.84%
2018 -NZ$36.98 Million7.22%
2017 -NZ$34.49 Million39.68%
2016 -NZ$24.69 Million-37.05%
2015 -NZ$39.23 Million6.94%
2014 -NZ$36.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.85 Billion 358.83%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.3 M-103.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$10.57 Million-94.27%๐Ÿ‡บ๐Ÿ‡ธ USA